Abbott Laboratories Newsroom

Abbott Laboratories Analyst Ratings

BenzingaJun 4 09:37 ET

Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115

MT NewswiresMay 30 09:17 ET

Abbott Laboratories Analyst Ratings

BenzingaMay 30 07:41 ET

Optimistic Buy Rating for Abbott Laboratories on Diverse Portfolio and Growth Prospects

TipRanksMay 30 04:27 ET

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

BenzingaMay 22 14:02 ET

Abbott Laboratories Analyst Ratings

BenzingaMay 22 13:18 ET

Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating

MT NewswiresMay 22 05:57 ET

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)

TipRanksMay 20 07:31 ET

Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), PolyPid (PYPD) and GoodRx Holdings (GDRX)

TipRanksMay 20 06:01 ET

Buy Rating Affirmed for Abbott Laboratories Based on Strong EP Business and Strategic Growth Prospects

TipRanksMay 20 04:20 ET

RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)

TipRanksMay 7 08:10 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 22 08:37 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 18 11:54 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 4 12:21 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 3 11:32 ET

Abbott Laboratories Analyst Ratings

BenzingaFeb 14 09:48 ET

Edwards Stock Jumps 8% on FDA Approval, Wells Fargo Upgrade

Seeking AlphaFeb 2 12:20 ET

Abbott Laboratories Analyst Ratings

BenzingaJan 26 13:20 ET

JPMorgan Raises Abbott Laboratories Price Target to $125 From $122, Maintains Overweight Rating

MT NewswiresJan 25 07:53 ET

RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT)

TipRanksJan 25 07:26 ET